ID   PGPC17_11_MYBPC3_KO
AC   CVCL_B5NH
DR   Wikidata; Q112129513
RX   PubMed=31813827;
CC   Population: Caucasian.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:7551; MYBPC3.
CC   Omics: Genomics; Whole genome sequencing.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B5NG ! PGPC17_11
SX   Male
AG   61Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=31813827; DOI=10.1016/j.stemcr.2019.11.003; PMCID=PMC6915802;
RA   Hildebrandt M.R., Reuter M.S., Wei W., Tayebi N., Liu J.-J., Sharmin S.,
RA   Mulder J., Lesperance L.S., Brauer P.M., Mok R.S.-F., Kinnear C.,
RA   Piekna A., Romm A., Howe J., Pasceri P., Meng G.-L., Rozycki M.,
RA   Rodrigues D.C., Martinez E.C., Szego M.J., Zuniga-Pflucker J.C.,
RA   Anderson M.K., Prescott S.A., Rosenblum N.D., Kamath B.M., Mital S.,
RA   Scherer S.W., Ellis J.;
RT   "Precision health resource of control iPSC lines for versatile
RT   multilineage differentiation.";
RL   Stem Cell Reports 13:1126-1141(2019).
//